Track Every Presidential Action. Understand the Impact.
AI-powered summaries of executive orders, proclamations, and memoranda.
Type
Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
President Donald Trump issued Executive Order 14336 to enhance the resilience of the American pharmaceutical supply chain by filling the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The order directs the Office of the Assistant Secretary for Preparedness and Response (ASPR) to develop a list of approximately 26 critical drugs and to secure a 6-month supply of active pharmaceutical ingredients (APIs) for these drugs, prioritizing domestic production when possible. The ASPR is tasked with preparing the SAPIR repository to receive and maintain these APIs within specified timelines. The order aims to reduce reliance on foreign sources for APIs and bolster national health and security interests.
Stay up to date on presidential actions
New executive orders and proclamations, straight to your inbox.
Aug 19, 2025
FR90th Anniversary of the Social Security Act
Jun 06, 2025
Eliminating Waste, Fraud, and Abuse in Medicaid
May 08, 2025
FRRegulatory Relief To Promote Domestic Production of Critical Medicines
President Donald Trump issued Executive Order 14293 on May 5, 2025, to streamline regulations and promote domestic production of critical medicines. The order directs the Food and Drug Administration (FDA) and other agencies to review and eliminate unnecessary regulations that hinder the development of pharmaceutical manufacturing in the United States. It aims to reduce the time and complexity involved in building and expanding pharmaceutical facilities by addressing regulatory barriers, enhancing inspection processes, and improving coordination among agencies. The goal is to make the U.S. a more competitive environment for producing safe and effective medicines, thereby strengthening national security and ensuring a resilient supply chain.
May 05, 2025
Regulatory Relief to Promote Domestic Production of Critical Medicines
President Donald Trump issued an order to streamline regulations for domestic pharmaceutical manufacturing to enhance national security and reduce dependency on foreign sources. The order directs the Secretary of Health and Human Services and the FDA Commissioner to review and eliminate unnecessary regulations that hinder the development of pharmaceutical manufacturing in the United States. It also calls for improvements in the inspection processes for both domestic and foreign manufacturing facilities. Additionally, the Environmental Protection Agency and the U.S. Army Corps of Engineers are tasked with updating their regulations to facilitate faster approval and expansion of manufacturing facilities. This action aims to make the U.S. a more competitive environment for the production of essential medicines.
Apr 18, 2025
FRLowering Drug Prices by Once Again Putting Americans First
On April 15, 2025, President Donald Trump issued Executive Order 14273, titled "Lowering Drug Prices by Once Again Putting Americans First," aimed at reducing prescription drug costs for Americans. The order directs several actions, including improving the Medicare Drug Price Negotiation Program for greater transparency and cost-effectiveness, stabilizing Medicare Part D premiums, and aligning the treatment of small molecule drugs with biological products. It also mandates the development of strategies to reduce prices for high-cost drugs for seniors, enhance Medicaid drug payment innovation, and streamline drug importation processes. Additionally, the order seeks to address anti-competitive practices by pharmaceutical manufacturers and improve transparency in pharmacy benefit manager fee disclosures.
Mar 11, 2025
FRNational Consumer Protection Week, 2025
President Donald J. Trump has proclaimed March 2 through March 8, 2025, as National Consumer Protection Week. This proclamation emphasizes the importance of protecting consumer rights, privacy, and transparency, which are deemed crucial for a thriving American economy. The President highlights actions taken to prevent regulatory overreach in cryptocurrency and ensure transparency in prescription drug advertisements. The week is dedicated to raising awareness about consumer protection, with local and federal agencies providing resources to help Americans safeguard their privacy and financial well-being.
Feb 28, 2025
FRMaking America Healthy Again by Empowering Patients With Clear, Accurate, and Actionable Healthcare Pricing Information
On February 25, 2025, President Donald Trump issued Executive Order 14221, titled "Making America Healthy Again by Empowering Patients With Clear, Accurate, and Actionable Healthcare Pricing Information." This order mandates the enforcement and enhancement of existing healthcare price transparency regulations, initially established in 2019 under Executive Order 13877. The order requires hospitals and health plans to disclose actual prices for services and prescription drugs, ensuring this information is standardized and easily comparable. The goal is to empower patients with meaningful pricing information to make informed healthcare decisions, thereby promoting a more competitive and affordable healthcare system. The Secretaries of the Treasury, Labor, and Health and Human Services are tasked with implementing these measures within 90 days.
Feb 25, 2025
Making America Healthy Again by Empowering Patients with Clear, Accurate, and Actionable Healthcare Pricing Information
President Donald Trump has issued an order aimed at enhancing healthcare price transparency to empower patients with clear and actionable pricing information. This directive builds on previous efforts by mandating hospitals and health plans to provide detailed pricing data, including actual prices for services and prescription drugs, in a standardized and easily comparable format. The order instructs the Secretaries of Treasury, Labor, and Health and Human Services to enforce these transparency regulations, ensuring compliance and improving enforcement policies. The goal is to support a competitive and affordable healthcare system by providing patients with the information they need to make informed decisions.
Jan 28, 2025
FRDelivering Emergency Price Relief for American Families and Defeating the Cost-of-Living Crisis
On January 20, 2025, President Donald Trump issued a memorandum directing executive departments and agencies to implement emergency measures aimed at reducing costs for American families. This action seeks to address the high cost of living, which the memorandum attributes to previous regulatory policies. The directive includes efforts to lower housing costs, cut unnecessary healthcare expenses, and remove regulations that increase the cost of home appliances. Additionally, it calls for creating job opportunities and eliminating climate policies deemed to raise food and fuel prices. The Assistant to the President for Economic Policy is tasked with reporting on the progress of these initiatives every 30 days.